Enhanced glucose metabolism in Tet-deficient mouse embryonic stem cells
Frontiers in Epigenetics and Epigenomics · 2024
DOI: 10.3389/freae.2024.1245823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Epigenetics and Epigenomics, 2024. Verfasst von Yuhan Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Interactions between epigenetics and metabolites play critical roles in regulating the pluripotency and differentiation of embryonic stem cells. Proper glucose metabolism and DNA methylation are essential for orchestrating accurate lineage specification and the normal functions of embryonic stem cells. However, the impact of Ten-eleven Translocation (TET)-mediated DNA methylation modifications on the metabolism of mouse embryonic stem cells (mESCs) remains less well defined. In this study, we investigated the consequences of Tet triple knockout (Tet-TKO) in mESCs and observed notable alterations in glucose metabolism. These changes were marked by enhanced glucose uptake and glycolysis, likely owing to the upregulation of genes critical for glucose metabolism. Furthermore, Tet-TKO mESCs exhibited defects in glucose-dependent differentiation, suggesting that cells with epigenetic defects might display metabolic vulnerability when exposed to external nutritional cues. Collectively, our findings establish the pivotal role of the TET family of dioxygenases in maintaining proper glucose metabolism and safeguarding stem cell lineage specification, thus enhancing our understanding of the intricate interplay between epigenetic modifications and cellular metabolism in stem cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States.
- Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States.
- Department of Translational Medical Sciences, Texas A&M University, Houston, TX, United States.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NHLBI NIH HHS
- Cancer Prevention and Research Institute of Texas
- National Institutes of Health
- Welch Foundation
- Leukemia and Lymphoma Society
Zitieren
APA
Yang, Y., Cavalier, M., Suris, A., Chen, K., An, C., Fan, J., Rivera, L., Fang, S., Guo, L., Zhou, Y., & Huang, Y. (2024). Enhanced glucose metabolism in Tet-deficient mouse embryonic stem cells. Frontiers in Epigenetics and Epigenomics. https://doi.org/10.3389/freae.2024.1245823
Vancouver
Yang Y, Cavalier M, Suris A, Chen K, An C, Fan J, et al. Enhanced glucose metabolism in Tet-deficient mouse embryonic stem cells. Frontiers in Epigenetics and Epigenomics. 2024. doi:10.3389/freae.2024.1245823
BibTeX
@article{Yang2024,
author = {Yang, Yuhan and Cavalier, Maryn and Suris, Ashley and Chen, Kevin and An, Claire and Fan, Jingyuan and Rivera, Logan and Fang, Shaohai and Guo, Lei and Zhou, Yubin and Huang, Yun},
title = {Enhanced glucose metabolism in Tet-deficient mouse embryonic stem cells},
journal = {Frontiers in Epigenetics and Epigenomics},
year = {2024},
doi = {10.3389/freae.2024.1245823}
}
EUVIMED